The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. | Trump's appointment follows his ...

BRS spokesperson Manne Krishank gave a strong counter to the claims of Medicover Hospitals that the hospital had no links ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

Revenue: US$2.73m (down 33% from 3Q 2023). Net loss: US$162.0m (loss narrowed by 8.5% from 3Q 2023). US$0.86 loss per share ...

A ‘Unified Digital Pharmacy Platform’ (UDPP) could serve as a digital healthcare solution for senior citizens, eliminating ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...